These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17095897)

  • 1. Levetiracetam in the prophylaxis of migraine with aura: a 6-month open-label study.
    Brighina F; Palermo A; Aloisio A; Francolini M; Giglia G; Fierro B
    Clin Neuropharmacol; 2006; 29(6):338-42. PubMed ID: 17095897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects.
    Young W; Shaw J; Bloom M; Gebeline-Myers C
    Headache; 2008; 48(10):1490-8. PubMed ID: 19076647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam prophylaxis in pediatric migraine--an open-label study.
    Pakalnis A; Kring D; Meier L
    Headache; 2007 Mar; 47(3):427-30. PubMed ID: 17371359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy.
    Specchio N; Boero G; Michelucci R; Gambardella A; Giallonardo AT; Fattouch J; Di Bonaventura C; de Palo A; Ladogana M; Lamberti P; Vigevano F; La Neve A; Specchio LM
    Epilepsia; 2008 Apr; 49(4):663-9. PubMed ID: 18266754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elderly patients with migraine: an open-label study on prophylaxis therapy with levetiracetam.
    Pizza V; Busillo V; Agresta A; Bisogno A; Capasso A
    Cent Nerv Syst Agents Med Chem; 2011 Mar; 11(1):31-4. PubMed ID: 21250937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy.
    Specchio LM; Gambardella A; Giallonardo AT; Michelucci R; Specchio N; Boero G; La Neve A
    Epilepsy Res; 2006 Sep; 71(1):32-9. PubMed ID: 16814521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam in tardive dyskinesia.
    Meco G; Fabrizio E; Epifanio A; Morgante F; Valente M; Vanacore N; Di Rosa AE; Morgante L
    Clin Neuropharmacol; 2006; 29(5):265-8. PubMed ID: 16960471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease.
    Bedlack RS; Pastula DM; Hawes J; Heydt D
    Amyotroph Lateral Scler; 2009 Aug; 10(4):210-5. PubMed ID: 18821142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
    Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Picotamide in migraine aura prevention: a pilot study.
    Allais G; D'Andrea G; Airola G; De Lorenzo C; Mana O; Benedetto C
    Neurol Sci; 2004 Oct; 25 Suppl 3():S267-9. PubMed ID: 15549555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a pine bark extract and antioxidant vitamin combination product as therapy for migraine in patients refractory to pharmacologic medication.
    Chayasirisobhon S
    Headache; 2006 May; 46(5):788-93. PubMed ID: 16643582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of levetiracetam in children with epilepsy younger than 2 years of age.
    Krief P; Li Kan ; Maytal J
    J Child Neurol; 2008 May; 23(5):582-4. PubMed ID: 18448575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acupuncture in migraine prevention: a randomized sham controlled study with 6-months posttreatment follow-up.
    Alecrim-Andrade J; Maciel-Júnior JA; Carnè X; Severino Vasconcelos GM; Correa-Filho HR
    Clin J Pain; 2008 Feb; 24(2):98-105. PubMed ID: 18209514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of levetiracetam in treating epilepsy associated with other medical conditions.
    Di Bonaventura C; Mari F; Fattouch J; Egeo G; Vaudano AE; Manfredi M; Prencipe M; Giallonardo AT
    Acta Neurol Scand; 2006 Feb; 113(2):82-6. PubMed ID: 16411967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of levetiracetam in Huntington disease.
    de Tommaso M; Di Fruscolo O; Sciruicchio V; Specchio N; Cormio C; De Caro MF; Livrea P
    Clin Neuropharmacol; 2005; 28(6):280-4. PubMed ID: 16340384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of levetiracetam for migraine prophylaxis: A systematic review.
    Watkins AK; Gee ME; Brown JN
    J Clin Pharm Ther; 2018 Aug; 43(4):467-475. PubMed ID: 29781197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of levetiracetam in Parkinson disease patients with levodopa-induced dyskinesia.
    Lyons KE; Pahwa R
    Clin Neuropharmacol; 2006; 29(3):148-53. PubMed ID: 16772814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.